- It's probably too early at this point. Obviously, there needs to be more research in, you know number one targeted measures or medications to prevent strokes in patients with silent MI but also we would need to do research to see if it's if it's even worth screening folks at either their primary care physician's office or otherwise, for silent infarcts to look for to look for it as a potential risk for stroke. So I think it's just a little too early at this point but I'm excited about the future science behind this. Think future steps would include a potential of potentially running a randomized clinical trial looking at patients with prior silent MI versus those without silent MI and potentially randomizing them to either anti-platelets like aspirin versus one of the newer anticoagulants to see if it reduces the risk of embolic stroke.